In general, BrM markers such as AE1/AE3, CK7, and EMA were consistently distributed across M0−M6, whereas M7−M10 was positively correlated with glioma characteristics, including WHO grade and IDH1 status. The gene discussed is SMARCA2; the disease is central nervous system cancer.